Published in Hospital Business Week, March 25th, 2007
"In order to study autologous-infused cell contribution to relapse as well as the long-term persistence of the transgene in hematopoietic cells following...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.